Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-Announces-Termination-Of-All-Amgen-Sponsored-Clinical-Studies-Of-Rilotumumab-In-Advanced-G-19443386/?utm_source=whatsapp&utm_medium=social&utm_campaign=share